SPONSOR
Huai'an First People's Hospital
Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Marginal Zone Lymphoma
Huai'an First People's Hospital is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Marginal Zone Lymphoma.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Huai'an First People's Hospital
How many clinical trials has Huai'an First People's Hospital sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Huai'an First People's Hospital, of which 1 are actively recruiting participants. These trials cover conditions including Marginal Zone Lymphoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Huai'an First People's Hospital research focus on?
Huai'an First People's Hospital clinical trials span Marginal Zone Lymphoma. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Huai'an First People's Hospital clinical trial?
To participate in a Huai'an First People's Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Huai'an First People's Hospital trials with current recruitment status updated daily.
Clinical Trials by Huai'an First People's Hospital
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology